The Saudi Arabia Atopic Dermatitis Therapeutics Market was valued at US $209 Mn in 2022, and is predicted to grow at (CAGR) of 10.3% from 2023 to 2030, to US $458 Mn by 2030. The key drivers of this industry include the rising prevalence of Atopic Dermatitis (AD), innovative drugs in the pipeline and evolving healthcare landscape. The industry is primarily dominated by players such as Sanofi, AbbVie, Pfizer, Regeneron, Eli Lilly, and Astellas, among others.
The Saudi Arabia Atopic Dermatitis Therapeutics Market is at around US $209 Mn in 2022 and is projected to reach US $458 Mn in 2030, exhibiting a CAGR of 10.3% during the forecast period.
Atopic dermatitis (AD), commonly known as eczema, is a persistent inflammatory skin condition characterized by redness, itching, and inflammation. It often manifests in localized patches on various body areas and can be exacerbated by factors such as dry skin, stress, and exposure to specific irritants or allergens. Prominent symptoms include intense itching, redness, dryness, and the appearance of small, fluid-filled blisters that may discharge fluid and form crusts. Treatment typically involves a comprehensive approach, incorporating the use of emollients for skin moisturization, topical corticosteroids to reduce inflammation, and, in severe cases, systemic immunosuppressants. Various pharmaceutical companies manufacture medications for atopic dermatitis, with notable examples including Regeneron Pharmaceuticals and Sanofi's Dupixent (Dupilumab), Pfizer's Eucrisa (Crisaborole), and Novartis's Elidel (Pimecrolimus).
It is estimated that the prevalence of AD in Saudi Arabia is approximately 20% in children and 2-10% in adults. The market is being driven by significant factors such as the rising prevalence of AD, steadily growing economy, and supportive government initiatives for the therapeutics industry. However, conditions such as limited affordability, a lack of human resources, and market saturation can restrict the growth and potential of the market.
Market Growth Drivers
Rising prevalence of AD: It is estimated that the prevalence of AD in Saudi Arabia ranges from 15-20% in children to about 2-10% of adults. It is most prevalent among children as compared to adults. The surge is driven by factors such as urbanization, lifestyle changes, and genetic predisposition, which propel the market forward in demand for new therapeutics.
Rising economic growth: The economic expansion in Saudi Arabia results in increased disposable income, empowering patients to afford pricier and more advanced treatments, such as biologics. Patients are becoming more knowledgeable and proactive in pursuing advanced treatment alternatives.
Supportive government initiatives: The Saudi government's commitment to enhancing healthcare infrastructure and facilitating access to specialized care positively impacts the atopic dermatitis market. Initiatives such as Vision 2030 highlight a focus on chronic disease management and personalized medicine, fostering a conducive environment for advanced therapeutics.
Market Restraints
Limited affordability: The cost of modern biological therapies is high, posing a financial obstacle for individuals with low incomes and potentially putting a burden on the healthcare system. Certain insurance plans may not include coverage for newer or specialized treatments, placing significant out-of-pocket costs on patients.
Lack of human resource: The uneven distribution of healthcare professionals and facilities throughout the country can present difficulties for certain populations in accessing specialized dermatological care.
Market saturation and competition: A plethora of low-cost generic topical steroids and emollients saturates the market, posing a challenge for newer, pricier therapies to gain traction. Effectively reaching patients in remote areas and creating awareness about advanced treatments necessitate strong marketing and distribution networks, which may be deficient in certain regions.
Vision 2030 is spearheading a significant overhaul in Saudi Arabia's healthcare sector. Major entities such as the Ministry of Health, the Council of Cooperative Health Insurance, and the SACB play active roles in shaping this landscape, already effecting notable changes, such as the introduction of mandatory health insurance for expatriates. These transformations open up extensive opportunities for pharmaceutical firms. Anticipated changes encompass heightened healthcare spending, enhancements in infrastructure, and potential privatization, all poised to further redefine the regulatory framework.
Securing licenses, particularly in pharmacies, now involves more stringent procedures in accordance with guidelines from the Saudi Food and Drug Authority (SFDA). Staying abreast of evolving regulations becomes essential for pharmaceutical businesses to capitalize on the escalating momentum in Saudi healthcare.
Key Players
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Drug Class
By Route of Administration
By Severity type
By Age Group
By Distribution channel
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?